Kambani yeSpain yemishonga yeRovi neSwiss company Roche vakabvumirana kuti mushonga mutsva uyu upokane kufutisa uye chirwere cheshuga, parizvino iri mudanho repamusoro rekuvandudzwa kwekiriniki, ichagadzirwa muSpain. Chibvumirano, chakataurirwa kuCNMV uye chakamirira kuumbwa mumazuva anouya, nzvimbo San Sebastián de los Reyes (Madrid) senzvimbo yekugadzira yekuzotevera kugovera kwepasirese.
Zvinoenderana nekufanotaura kwakaunzwa nemakambani neHurumende, chirongwa ichi chinoburitsa a hupfumi hwehupfumi hunodarika 2.000 bhiriyoni euros muSpain uye ichasimudzira kugadzirwa kwemabasa ane hunyanzvi. KuRovi, chibvumirano chinomiririra kukurudzira kwakakosha kune yechitatu-bato rekugadzira bhizinesi, ine Kukura kwekutengesa kunofungidzirwa pa20% -25% muna 2030.
Chibvumirano, zvakadzama
Rovi, kuburikidza nerubatsiro rwayo Rois, ichaita kuti iwanikwe kuRoche mutsara wekuzadza-kumhanya panzvimbo yayo muSan Sebastián de los Reyes. Kugadzirwa kuchave zvachose muSpain uye kurapwa kwekufutisa Ichatengeswa pasi rose kana kukiriniki kwayo kwapera uye mvumo yakakodzera yawanikwa.
- Kugadzirwa kwakazara pachirimwa San Sebastián de los Reyes (Madrid).
- Kushandisa a high-speed kuzadza mutsara zvemajekiseni.
- Kurapa mu advanced clinical development phase.
- Kugoverwa kwepasi rose kuburikidza neRoche's international network.
Vachibva kuRovi vanotara chinzvimbo chavo vachiti Strategic kugadzira shamwari, mhedzisiro yemakore ekudyara mukugona uye tekinoroji yakatarisana nemajekiseni. Roche, kune chikamu chayo, inosimbisa kuvepo kwayo muSpain yakakwana kukosha cheni inovhara kutsvagisa, kuongororwa, kugadzira uye kushambadzira.
Economic uye bhizinesi kukanganisa paRovi
The Executive inofungidzira kuti chirongwa ichi chichasimudzira hupfumi nezvakawanda kupfuura 2.000 mamiriyoni emamiriyoni pakati pezvakananga uye zvisina kunanga zvinokonzeresa, zvichifarira kukwezva kwekudyara uye kuendesa ruzivo. KuRovi, kurongeka kunoguma nekuwedzera kushoma pakati 20% uye 25% yekutengesa kubva kubhizinesi rayo rekugadzira kusvika kune vechitatu mapato panosvika 2030.
Mukutaura kwemari, iyi nhanho yakaenzana nemupiro we pakati pe67,2 ne84,5 miriyoni euros muna 2030, maererano nekufungidzira kwekambani. Musika wemasheya wakaita zvakanaka kune chiziviso ichi, migove yeRovi ichikwira. inenge 6%.
Pamusoro peiyo macroeconomic athari, mubatanidzwa unopa iyo kugadzira mabasa ane hunyanzvi uye kubatanidzwa kwepamusoro-kukosha kwemaindasitiri zvivakwa, kusimbisa nzvimbo yeSpain mumunda we biomedical innovation uye kutengeswa kunze kwenyika mishonga yemhando yepamusoro.
Institutional rutsigiro uye hurongwa hwemaindasitiri
Mutungamiriri weHurumende, Pedro Sánchez, vakasangana muMoncloa neMukuru weRoche, Thomas Schinecker, mutungamiri weRovi, Juan López-Belmonte, uye maneja mukuru weRoche Spain, Patrick Wallach. Ruzivo rwechibvumirano uye kuenderana kwayo nemitemo yeruzhinji ye kukurudzira chizvarwa chinotevera chekugadzirwa kwemishonga.
The Executive inoronga kushanda uku mu Pharmaceutical Industry Strategy 2024-2028 uye mumitsara yeKudzoreredza, Shanduko uye Resilience Chirongwa, ichiratidza kubatana kweveruzhinji-yakavanzika uye kukwezva mari yekunze semarevheti ekusimudzira hupfumi nemabasa emhando yepamusoro.
Mamiriro eprojekiti uye matanho anotevera
Kondirakiti iri muchikamu chekupedzisira uye kuurayiwa kunotarisirwa siginicha yekupedzisira mumazuva mashoma anoteveraMushonga, unova we metabolic uye mwoyo nzvimbo Roche's portfolio inoenderera mberi nekuvandudzwa kwekiriniki netarisiro yekugovaniswa pasi rose kana nzira dzekutonga dzapera.
Nekubatana uku, Roche ichave nechokwadi chekupihwa kweramangwana rekurapa kutsva kwe zvirwere zvakanyanya, nepo Rovi inobata pahunyanzvi hwetekinoroji yechirimwa chayo cheMadrid kuyera kugadzirwa nemhando dzepasi rose.
Kubatana pakati peRoche neRovi kunoisa Spain munzvimbo yakasimbiswa mukati meEuropean biopharmaceutical indasitiri: kugadzirwa kwenzvimbo yekurapa kwehunyanzvi, fungidziro yepasirese, kukanganisa kwakakosha kwehupfumi, uye nzira yakajeka yekuwedzera kukwikwidza kwemaindasitiri uye mabasa ane hunyanzvi munyika.
